Health scare of the week: A TB strain that can’t be treated

Twelve tuberculosis patients in India have failed to respond to the antibiotics doctors prescribed.

A dozen tuberculosis patients at a Mumbai hospital have failed to respond to any treatment, sparking fears that a totally drug-resistant TB strain could be spreading. The lung disease, which kills roughly 1.5 million people worldwide every year, was once easily treatable with antibiotics. But in recent years, varieties resistant to one or more drugs have proliferated around the world.

Researchers say patients often fail to complete the six- to nine-month course of antibiotics required to destroy TB bacteria, allowing some microbes to survive and mutate into harder-to-kill forms. That’s the suspected cause of the new Indian strain, which will “spread for sure” among the country’s dense population, Zarir Udwadia, one of the doctors who discovered the bacteria’s resistance, tells the Associated Press.

Almost one in three people around the globe harbors dormant TB bacteria, and the disease becomes active in 10 percent of them. A contagious individual can infect some 20 more people per year. The patients diagnosed with the new Indian strain are “probably just the tip of the iceberg,” says Ruth McNerney, a lecturer at the London School of Hygiene and Tropical Medicine. “This is a global problem, not just an Indian one.”

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us